New three-year results from the EARLY AF trial confirm that “first-line” treatment of paroxysmal atrial fibrillation with Medtronic’s Arctic Front cryoballoon ablation system yields better long-term results than trying antiarrhythmic drugs first.
The one-year results from EARLY AF showed that patients treated with pulmonary vein isolation ablation with a cryoballoon were less likely to experience a recurrence of atrial fibrillation, atrial tachycardia,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?